Acufocus,

AcuFocus, Inc., is a privately held ophthalmic medical device company that delivers breakthrough small-aperture intraocular products to address diverse unmet needs in eye care and help patients achieve their best personal vision. The IC-8® Apthera™ IOL (known as the IC-8 IOL internationally) is approved in the United States for the treatment of cataract patients. The Apthera IOL uses small aperture technology to filter out peripheral defocused light, allowing only focused light to reach the retina. This provides a true continuous depth of focus with patients with as much as 1.5 diopters (D) of corneal astigmatism. The lens also received CE mark in 2015 and is available in select markets across Europe as well as Australia, New Zealand, and Singapore. AcuFocus is based in Irvine, California. For more information about AcuFocus, visit www.acufocus.com. For Apthera IOL safety information, please visit www.acufocus.com/our-technology.